Oxford+ In Brief with Peter Donnelly, CEO and Co-Founder of Genomics

What would healthcare look like if genetics were built into drug discovery and disease prevention? In this Oxford+ in Brief episode, Susannah de Jager puts five quick-fire questions to Sir Peter Donnelly, CEO and co-founder of Genomics. Peter describes a future in which genetic evidence helps researchers develop medicines and select patients, while healthcare systems direct screening and prevention to the people who need them at the right time. He hopes this could lead to more effective medicines and longer, healthier lives. Peter also offers advice to founders entering Oxford: understand the demands, stay close to the mission and choose good colleagues.  Susannah de Jager: Susannah is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital. Connect with Susannah on LinkedIn and Subscribe to the Oxford+ Newsletter for Exclusive Content Oxford+ is hosted by Susannah de Jager and supported by Mishcon de Reya, HSBC Innovation Banking, and James Cowper Kreston. Produced and Edited by Story Ninety-Four in Oxford.